Cronos Group Inc vs Spotify Technology — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while Spotify Technology trades at $480.5 (market cap $98.92B). The key difference: Spotify Technology is far larger — about 97× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals.
| CRON | SPOT | |
|---|---|---|
Market Cap | $1.02B | $98.92B |
Sector | Health | Media |
52-Week High | $3.27 | $738.53 |
52-Week Low | $1.95 | $412.75 |
Enterprise Value | $203.29M | $89.50B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
Spotify (SPOT) trades at $479.84, showing minimal daily movement (+0.01%) amid neutral technical signals. The company demonstrates strong fundamental momentum with revenue growing from $11.7B in 2022 to $17.2B in 2025, while achieving profitability turnaround from losses to $2.2B net income. Recent earnings beats and AI integration initiatives highlight operational strength, though technical indicators show mixed signals with bearish moving averages and neutral oscillators.
Spotify presents a compelling growth story with accelerating profitability and analyst optimism (61.5% buy ratings), though faces execution risks in competitive streaming markets. The stock trades at a premium valuation (P/E 32.7) but offers 28% upside to consensus target of $617. Key risks include market saturation and royalty cost pressures, while AI innovation provides growth catalysts.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →